Stay updated with breaking news from Cytovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
‘Vivek’s first business had a subsidiary in China’ which was closed ‘as the risks of doing business in China became apparent,’ Ramaswamy spokesperson says
The 2024 Republican presidential candidate has come under fire for previously doing business with a company owned by the Chinese government.
Republican presidential candidate Vivek Ramaswamy is taking a hawk-like approach to China after previously doing business in the Communist state as the CEO of Roivant.
The former CEO of biotech company Roivant has done a 180-degree turn on Chinese business opportunities leading up to his presidential run.
BioNTech is acquiring a preclinical T cell receptor program (TCR) from Medigene, as well as licenses to the biotech’s TCR technologies. The agreement helps BioNTech expand its scope in cancer immunotherapy with a new approach for addressing solid tumors.